• About
  • Advertise
  • Careers
  • Write for us
  • Contact
  • Terms of service
Friday, May 20, 2022
The Millennial Source
TMS
Home WORLD

Clinical trials on promising new all-cancer cure likely to begin this year

byDhipa Palani
January 24, 2020
in WORLD
Share on FacebookShare on TwitterShare on Linkedin



Recent advancements in an immune cell cancer treatment made by a Cardiff University team has found a new part of our immune system that can be used to treat all cancers. 

The study is still in its preliminary stages and has yet to be tested on people.

Although “promising,” however, researchers say it would take “many years” for the new immune cell cancer treatment, which can reportedly attack a variety of cancers without needing tailored treatment, to be made available to the public. 

Cardiff University researcher Professor Andrew K. Sewell told The Millennial Source that only a handful of patients will be selected to undergo a series of clinical trials set to begin as early as late this year.

“While we hope to enter clinical trials later this year or early next year, this will be for a handful of patients in-series. It is important that we know the therapy is safe and there is an established, standard pipeline to follow for this,” Sewell said. 

The treatment has yet to be tested on a patient and is only “promising basic science result in the laboratory,” Sewell said.

How the immune cell treatment differ from chemotherapy or radiation therapy treatments

According to the findings published on Nature Immunology, Cardiff University researchers found that the T-cell, which is a type of white blood cell, is activated when in contact with defective or foreign cells in the body, which helps us fight off infections and diseases. 

T-cell cancer therapies involve the removal and modification of a patient’s T-cells by adding an artificial receptor to the surface of the cell. These T-cells are later returned into the patient’s bloodstream, which scan the body to look for cancer and tumor cells that need to be removed. 

Unlike the common treatment for cancers, the new immune cell treatment did not harm non-cancerous cells or normal tissues tested in the laboratory. 

Chemotherapy is an invasive treatment that has produced side effects to its patients, during and after the therapy. Furthermore, the drugs used in chemotherapy treatments often target both cancer cells and healthy cells.

Radiation therapy, on the other hand, treats cancer by blasting high-energy waves to kill tumor cells in order to eliminate cancer without damaging too many healthy cells. 

Is the new immune cell therapy really a one-size-fits-all cancer cure? 

The scientists have tested the T-cell and its receptor on various types of cancers in mice and in human cells in the lab, which resulted in positive outcomes. 

“In the laboratory, the cells actually killed most types of cancer we’ve tried them with,” Sewell said in an interview with the BBC.

Existing T-cell treatment

Existing immunology treatments with T-cell extraction activates the body’s natural defenses to fight cancer cells called chimeric antigen receptor T cell therapy. It is commonly used in treating blood cancers such as B-cell lymphoma, mantle cell lymphoma, multiple myeloma and acute myeloid leukemia.

Although the CAR T-Cell therapy has an 80 percent success rate, this form of treatment is not effective on “solid cancers.”

“Solid cancers” make up most cancers which are those that form tumors rather than blood cancers. Furthermore, existing T-cell treatment also causes temporary but severe side effects on most of its patients, such as changes in the brain that cause swelling, confusion and seizures.

[article_ad]

Related

Tags: North AmericaShort read
ShareTweetShare

Latest Posts

SEC Wall Street

The US SEC investigates Wall Street over use of unapproved messaging apps

May 19, 2022
US recession

There is a “very, very high risk” of a US recession, says Goldman Sachs Chairman Lloyd Blankfein

May 17, 2022
interest rates

US hikes rates by half-percentage point, rules out bigger future rate increases

May 5, 2022

What is the US Supreme Court abortion law leak, and why does it matter?

May 4, 2022

What you need to know about Pelosi’s secret trip to Kyiv

May 2, 2022

Warren Buffett is on a spending spree putting US$41 billion to work this quarter

May 2, 2022

Fed Chair Powell flags sharp rate hike next month

April 22, 2022

Goldman warns of a rate hike until inflation settles

January 23, 2022

Plan a weekend getaway at these 6 perfect lake destinations

October 12, 2021

SUBSCRIBE TO THE TMS NEWSLETTER

By providing your email, you agree to our Privacy Policy

The Millennial Source Ltd. 2021

No Result
View All Result
  • Your daily briefing
  • About us
  • Explore
    • Startups
    • Climate change
    • Tech giants
    • Crypto
    • The future of work
    • Banking giants
    • Economy
  • Lifestyle
  • TMS archives
  • Write for us
  • Contact
  • Privacy Policy & Terms

© 2022 The Millennial Source Ltd.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

string(24) "jsonld single post debug"
The Millennial Source
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.